T7Z-31628-46068
2 vaccinations
4 coded responses
14 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 534 / WI
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-13
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Registered in v-safe
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-04-27
Survey response — day 0, dose 2MedDRA: Pre-existing disease, Raynaud's phenomenon — Feeling: FairFree text: Unexpectes flare up of Raynaud'sMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-04-30
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
-
2021-07-27
Survey response — 3 months, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Exhaustion. Tired all the timeMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-26
Survey response — 6 months, dose 2MedDRA: Menstrual disorder — Feeling: FairFree text: Menstruation issues are worse.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Survey response — 12 months, dose 2MedDRA: Constipation, Menstrual disorder, Polymenorrhoea — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Chronic constipation. Still issues with menstrual cycle. Period occurs every 10-12 days since May 2021, a month after receiving the vaccine.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 0, dose 2
Systemic reaction (other): Unexpectes flare up of Raynaud's
Release 9 — 3 months, dose 2
Symptoms: Exhaustion. Tired all the time
Release 10 — 6 months, dose 2
Symptoms: Menstruation issues are worse.
Release 11 — 12 months, dose 2
Symptoms: Chronic constipation. Still issues with menstrual cycle. Period occurs every 10-12 days since May 2021, a month after receiving the vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Constipation | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Polymenorrhoea | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Raynaud's phenomenon | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release